Lantheus Holdings Analyst Ratings
Jefferies Reaffirms Their Buy Rating on Lantheus (LNTH)
Buy Rating Affirmed for Lantheus Holdings With Enhanced Revenue Projections and Strategic Expansion
Inari Medical Analyst Ratings
UFP Techs Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Oric Pharmaceuticals (ORIC), Ufp Technologies (UFPT)
Silk Road Medical Analyst Ratings
Inari Medical Analyst Ratings
Truist Securities Maintains Hold on Inari Medical, Raises Price Target to $60
Integra Lifesciences: Strategic Manufacturing Shifts Amid Supply Constraints – A Hold Rating Perspective
Truist Raises Price Target on Integra LifeSciences Holdings to $32 From $25, Maintains Hold Rating
Truist Raises Price Target on Globus Medical to $78 From $63, Maintains Hold Rating
Integra Lifesciences Sell Rating Justified by Production Delays and Overvalued Stock
Integer Holdings Analyst Ratings
Integra Lifesciences Analyst Ratings
Globus Medical Analyst Ratings
Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $71
Morgan Stanley Raises Price Target on Integra LifeSciences to $27 From $24, Keeps Underweight Rating
Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating
Morgan Stanley Raises Price Target on Globus Medical to $71 From $67, Keeps Equalweight Rating